Lv416
438 积分 2023-09-18 加入
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
19分钟前
待确认
GPCR drug discovery: new agents, targets and indications
11天前
已完结
Brain-shuttle biologics chart new paths across the blood–brain barrier
11天前
已完结
20 years of taxane therapy in prostate cancer — the past, present and future
24天前
已完结
Antibody–drug conjugates in gynaecological cancers: opportunities and challenges
24天前
已完结
Cancer burden and control in China: landscape, trends and challenges
24天前
已完结
AACR 2026
24天前
已完结
Imaging the hallmarks of cancer
24天前
已完结
T cell engagers in autoimmune diseases
24天前
已完结
皖公网安备34019202002308
